Beyond the Blood Cell: The Emerging Role of Cell-Free DNA in Transfusion Medicine

Area of Science:

• * Transfusion Medicine
• * Molecular Biology
• * Immunology

Background:

• * Cell-free DNA (cfDNA) is fragmented DNA in circulation, crucial for diagnostics.
• * cfDNA in transfused blood products presents new clinical challenges.
• * Donor cfDNA can lead to transfusion-associated microchimerism in recipients.

Purpose of the Study:

• * To review the persistence and immunologic impact of donor cfDNA in transfusion recipients.
• * To examine the potential for cfDNA genomic integration and immune pathway activation.
• * To highlight the limitations of current leukoreduction in cfDNA removal.

Main Methods:

• * Synthesis of current scientific literature on cfDNA in transfusion.
• * Analysis of evidence regarding cfDNA persistence, integration, and immune effects.
• * Evaluation of existing blood processing techniques, including leukoreduction.

Main Results:

• * Donor cfDNA can persist long-term in transfusion recipients.
• * cfDNA may integrate into the host genome and alter epigenetic modifications.
• * Innate immune pathways, like Toll-like receptors, can be activated by cfDNA.
• * Environmental or dietary DNA in transfused cfDNA may influence immune regulation.
• * Leukoreduction does not eliminate cfDNA or prevent microchimerism.

Conclusions:

• * Donor cfDNA poses potential risks including immune activation and genomic alterations.
• * Current blood processing methods are insufficient to mitigate cfDNA-related risks.
• * Further research and improved blood processing are essential for transfusion safety.